Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of February 23rd, we are planning to work on 16 projects, including:

Reimbursement

1. Delivering reimbursement analysis for novel technology in organ transplantation in France
2. Delivering a market access strategy for invasive diagnostic imaging technology in the cardiovascular area in England, France, and Germany
3. Delivering reimbursement analysis for surgical treatment in the orthopedic area in Germany and Switzerland
4. Delivering reimbursement analysis for diagnostic and therapeutic procedures in the cardiovascular area in England, France, Germany, and Italy
5. Working on market access strategy for minimally invasive technology in the urology area in eight European countries
6. Working on reimbursement analysis for extracorporeal treatment in ten European countries
7. Working on reimbursement analysis for an in-vitro diagnostic test in the hematology area in England, France, Germany, and Italy
8. Working on reimbursement analysis for minimally invasive technology in the neurology area in Denmark, Finland, Norway, and Sweden
9. Working on reimbursement analysis for an in-vitro diagnostic test in the oncology area in France, Germany, Italy, and Spain

HEOR

1. Delivering a clinical value dossier for treatment technology in the dermatology area
2. Delivering a value dossier update for an in-vitro diagnostic test in the oncology area
3. Delivering two systematic literature reviews for a minimally invasive technology in the neurology area
4. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
5. Working on the adaptation of a health economic model for an imaging diagnostic system in different European and Middle Eastern countries
6. Working on the validation of a health economic model in the cardiology area
7. Working on a systematic literature review and meta-analysis for an in vitro diagnostic test

Let us know if you need any market access or HEOR support for your medical technology in Europe.